Angel maintains BUY rating on Sun Pharma despite 11 US FDA observations
Most Popular (6 hours)

Bitcoin versus gold

- business-standard

Counter-productive move

- business-standard

JKPSC Datesheet

- dailyexcelsior.com

Most Popular (24 hours)

Most Popular (a week)

RSS leader hacked in Kannur

- kaumudiglobal.com

Samvat 2074: The macro picture

- moneycontrol.com

Angel maintains BUY rating on Sun Pharma despite 11 US FDA observations

Angel Broking maintained its BUY rating on Sun Pharmaceutical Industries with a price target of Rs 847, even as the pharma major received 11 observations the US Food and Drug Administration (FDA) for its Dadra unit. The post Angel maintains BUY rating on S

Read on the original site


Old walls posing risk to people

- dailyexcelsior.com

Diwali gift for jawans on borders

- dailyexcelsior.com

F ES Deptt generates awareness

- dailyexcelsior.com

Minor girl drowns in water tank

- dailyexcelsior.com

PE-backed IPOs ride on bulls

- business-standard

Gold futures up by Rs 71

- dailyexcelsior.com
Hashtags:   

Angel

 | 

maintains

 | 

BUY

 | 

rating

 | 

Sun

 | 

Pharma

 | 

despite

 | 

FDA

 | 

observations

 |